RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept

Octahydroisoquinoline compounds as opioid receptor modulators

Carroll, F., Navarro, H., Mascarella, S., & Thomas, J. (2009). Octahydroisoquinoline compounds as opioid receptor modulators. (U.S. Patent No. 7476679). http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=7476679

Abstract

Compounds which bind to opioid receptors are provided. In a preferred embodiment of the invention, the compounds are opioid receptor antagonists. The present invention also provides methods of treating conditions which are mediated by an opioid receptor.

Download/Explore

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Presidential youth fitness program implementation
Article

Estimating regionalized planning costs of green infrastructure and low-impact development stormwater management practices
Article

Alpha-pyrrolidinopentiophenone and mephedrone self-administration produce differential neurochemical changes following short- or long-access conditions in rats
Article

Screening for vitamin d deficiency in adults